Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · IEX Real-Time Price · USD
-0.100 (-2.25%)
At close: Jul 17, 2024, 4:00 PM
+0.300 (6.90%)
After-hours: Jul 17, 2024, 7:33 PM EDT

Adaptive Biotechnologies Revenue

Adaptive Biotechnologies had revenue of $174.50M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $41.87M with 11.23% year-over-year growth. In the year 2023, Adaptive Biotechnologies had annual revenue of $170.28M.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
641.05M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 2023170.28M-15.03M-8.11%
Dec 31, 2022185.31M30.96M20.06%
Dec 31, 2021154.34M55.96M56.88%
Dec 31, 202098.38M13.31M15.65%
Dec 31, 201985.07M29.41M52.83%
Dec 31, 201855.66M17.22M44.77%
Dec 31, 201738.45M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Pediatrix Medical Group 2.00B
Varex Imaging 855.80M
Orthofix Medical 760.05M
Pharming Group 280.83M
Surmodics 142.96M
IRadimed 67.69M
Verve Therapeutics 16.05M
Revenue Rankings